202 related articles for article (PubMed ID: 32477929)
1. Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation.
Incekara F; van der Voort SR; Dubbink HJ; Atmodimedjo PN; Nandoe Tewarie R; Lycklama G; Vincent AJPE; Kros JM; Klein S; van den Bent M; Smits M
Front Oncol; 2020; 10():596. PubMed ID: 32477929
[No Abstract] [Full Text] [Related]
2. O
Alassiri AH; Alkhaibary A; Al-Sarheed S; Alsufani F; Alharbi M; Alkhani A; Aloraidi A
Ann Saudi Med; 2019; 39(6):410-416. PubMed ID: 31804140
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of partial
Torre M; Wen PY; Iorgulescu JB
Neurooncol Pract; 2023 Apr; 10(2):126-131. PubMed ID: 36970171
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of
Lam K; Eldred BSC; Kevan B; Pianka S; Eldred BA; Zapanta Rinonos S; Yong WH; Liau LM; Nghiemphu PL; Cloughesy TF; Green RM; Lai A
Neurooncol Adv; 2022; 4(1):vdac030. PubMed ID: 35386566
[TBL] [Abstract][Full Text] [Related]
5. Relationship between molecular characteristics of glioblastoma multiforme and the subventricular zone.
Ashraf M; Abdelsadg M; Grivas A
Br J Neurosurg; 2022 Jan; ():1-8. PubMed ID: 35038937
[TBL] [Abstract][Full Text] [Related]
6. The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma.
Incekara F; Smits M; van der Voort SR; Dubbink HJ; Atmodimedjo PN; Kros JM; Vincent AJPE; van den Bent M
Front Oncol; 2020; 10():1087. PubMed ID: 32766140
[No Abstract] [Full Text] [Related]
7. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
8. Prediction of O(6)-methylguanine-DNA methyltransferase promoter methylation status in IDH-wildtype glioblastoma using MRI histogram analysis.
Liu X; Han T; Wang Y; Liu H; Zhou J
Neurosurg Rev; 2024 Jun; 47(1):285. PubMed ID: 38907038
[TBL] [Abstract][Full Text] [Related]
9. Pyrosequencing Analysis of O-6-Methylguanine-DNA Methyltransferase Methylation at Different Cut-Offs of Positivity Associated with Treatment Response and Disease-Specific Survival in Isocitrate Dehydrogenase-Wildtype Grade 4 Glioblastoma.
Silva FFVE; Di Domenico M; Caponio VCA; Pérez-Sayáns M; Camolesi GCV; Rojo-Álvarez LI; Ballini A; García-García A; Padín-Iruegas ME; Suaréz-Peñaranda JM
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203783
[TBL] [Abstract][Full Text] [Related]
10. MGMT promoter methylation in 1p19q-intact gliomas.
Kinslow C; Siegelin MD; Iwamoto FM; Gallitto M; Neugut AI; Yu JB; Cheng SK; Wang TJC
Res Sq; 2023 Oct; ():. PubMed ID: 37886555
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
12. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
Bunevicius A; Pikis S; Kondziolka D; Patel DN; Bernstein K; Sulman EP; Lee CC; Yang HC; Delabar V; Mathieu D; Cifarelli CP; Arsanious DE; Dahshan BA; Weir JS; Speckter H; Mota A; Tripathi M; Kumar N; Warnick RE; Sheehan JP
J Neurosurg; 2022 Jul; 137(1):42-50. PubMed ID: 34740186
[TBL] [Abstract][Full Text] [Related]
14. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in glioma.
Xie Z; Li J; Zhang Y; Zhou R; Zhang H; Duan C; Liu S; Niu L; Zhao J; Liu Y; Song S; Liu X
Front Neurosci; 2022; 16():1099019. PubMed ID: 36711137
[TBL] [Abstract][Full Text] [Related]
16. Correlation of commercially available quantitative
Dovek L; Nguyen NT; Ozer BH; Li N; Elashoff RM; Green RM; Liau L; Nghiemphu PL; Cloughesy TF; Lai A
Neurooncol Pract; 2019 May; 6(3):194-202. PubMed ID: 31386024
[TBL] [Abstract][Full Text] [Related]
17. Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.
Gessler F; Bernstock JD; Braczynski A; Lescher S; Baumgarten P; Harter PN; Mittelbronn M; Wu T; Seifert V; Senft C
Neurosurgery; 2019 Jan; 84(1):190-197. PubMed ID: 29617848
[TBL] [Abstract][Full Text] [Related]
18. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR
Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694
[TBL] [Abstract][Full Text] [Related]
19. Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
Houdova Megova M; Drábek J; Dwight Z; Trojanec R; Koudeláková V; Vrbková J; Kalita O; Mlcochova S; Rabcanova M; Hajdúch M
Klin Onkol; 2017; 30(5):361-371. PubMed ID: 29031038
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Analysis of the
Häni L; Kopcic M; Branca M; Schütz A; Murek M; Söll N; Vassella E; Raabe A; Hewer E; Schucht P
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]